HTID#4 Agenda

Thursday, October 13th 2022

08:30am - 8:55am (CET)

Opening ceremony

• Maryvonne Hiance President of HealthTech For Care
• Additionnal Speakers to be confirmed

09:00am - 9:50am

Build tomorrow’s healthcare for all European citizen

• Christian Pierret Former Minister of Industry (moderator)
• Michel Goldman President I3h Institute at the Free University of Brussels
• Additionnal Speakers to be confirmed

09:50am - 10:05am

10:05am - 10:55am

Funding Innovation: is there a creative approach smarter than pouring money?

• Philippe Lopes-Fernandes Executive Vice President, Chief Business Officer, Member of the Executive Committee, at Ipsen (moderator)
• Laurent Arthaud Managing Director for Investments in Lifesciences, Ecotechnologies and French Tech at Bpifrance
• Iordanis Arzimanoglou EIC Programme Manager for Health and Biotechnology
• Jean-Marc Bourez CEO ad interim at EIT Health, Managing Director EIT Health France
• Enric Claverol-Tinturé EIC Programme Manager for medical technologies and medical devices
• Johanna Michielin Head at Biolabs France

11:00am - 12:10pm

Age-related diseases, a continuum from birth to death

• Antoni Montserrat Vice President at the Luxembourg National Committee for rare diseases (moderator)
• André Baruchel Professor of Paediatrics - Head of Department at APHP, University of Paris
• Ross Jeggo Global Head of Neuroscience and Immuno-inflammation Therapeutic Area at Servier
• Carlos Buesa Founder and Chairman at Oryzon
• Walid Kamoun Vice President, Global Head of R&D Oncology at Servier
• Jean Mariani Professor Emeritus at Sorbonne University, Director of the Institute of Longevity
• Additionnal Speakers to be confirmed

12:10pm - 01:20pm

01:20pm - 01:40pm

R&D collaboration led by Bristol Myers Squibb

• Additionnal Speakers to be confirmed

01:45pm - 02:25pm

Prospective scenario of the health system in 2032 and perspective at European level

• Additionnal Speakers to be confirmed

02:30pm - 03:25pm

Covid wake up call on health innovation investments - – Opportunities and turbulence

• Cédric Moreau Partner at Sofinnova Partners (moderator)
• Yann Le Flohic Country Director Life Sciences Acceleration Alliance,Co-founder Allison+Partners PR France
• Elena Coluccelli-Guérin Managing Partner, Healthcare M&A, focus on mid cap at Rothschild & Co
• Aniz Girach Ophthalmologist, Board Director, Chief Medical Officer at ProQR Therapeutics

03:25pm - 03:45pm

03:45pm - 04:10pm

TR Dechert

• Sophie Pelé Lawyer at Dechert LLP
• Edward Kliphuis Partner at Sofinnova Partners
• Simon Turner Partner at Sofinnova Partners
• Alain Decombe Deputy Chair for International Operations, Paris Managing Partner at Dechert LLP

04:15pm - 05:10pm

How AI is revolutionizing the patient-doctor relationship

• Emmanuelle Trombe Lawyer and Partner at McDermott Will & Emery (moderator)
• Patrick Boisseau Director General, Strategic Initiatives at MedTech Europe
• Karine Samama Healthcare and life sciences strategy and partnerships executive at Microsoft
• Koen Cobbaert Senior Manager - Quality, Standards & Regulations at Philips
• Katja Niedermeier Specialist in general medicine, diabetologist at Praxis
• Clara Moschetti Innovation Projects Manager at StatupInside and AI For Health

05:15pm - 06:15pm

Translational microbiome medicine to treat serious oncology and infectious diseases

• Isabelle de Cremoux CEO and Managing Partner at Seventure Partners (moderator)
• Hervé Affagard Founder and CEO at MaaT Pharma
• Per Falk President at Ferring Pharmaceuticals
• Mohamad Mohty Professor of Hematology at Sorbonne University, and head of the Clinical Hematology and Cellular Therapy Department at Saint-Antoine Hospital
• Mike Romanos CEO at Microbiotica
• Hassane Zarour Professor of Medicine, Immunology and Dermatology, University of Pittsburgh

06:15pm - 06:30pm

06:30pm - 06:45pm

Keynote Jeito Capital

• Sabine Dandiguian Managing Partner at Jeito

06:50pm - 07:30pm

Institutional

• Institutional to be confirmed

Friday, October 14th 2022

08:45am - 9:25am (CET)

In vitro diagnostics industry in Europe : at the heart of patient’s care

• Marie Anson PhD in Immunology, Project manager at EIT Health
• Gérald Ulrich CEO of Quantamatrix Europe
• Additionnal Speakers to be confirmed

09:30am - 10:05am

IPO testimonials & expectations

• Franck Grimaud President & CBO at VALNEVA
• Michael Kloss CEO and Co-founder of eureKING
• Camille Leca Head of Listing France, Portugal & Spain at Euronext
• Jean Luc Vandebroek Chief Financial Officer, IR and Communication at Hyloris Pharmaceuticals

10:05am - 10:15am

10:15am - 11:05am

Matching the required talents for a sustainable development: constraints and opportunities!

• Frederik Alberchtsen Consultant at Russell Reynolds Associates (moderator)
• Claude Bertrand Executive Vice President R&D at Servier
• Elsy Boglioli Hofman Founder and CEO at Bio-Up
• Marie Catoire General Secretary at TreeFrog Therapeutics
• Bernard Gilly CEO at GenSight Biologics
• Vanessa Malier Managing Partner at Kurma Partners

11:10am - 12:05pm

Impact of mRNA application in innovative drugs with the support of adapted manufacturing settings (In the memory of François Gros)

• Sylvain Gariel Co-founder and COO of DNA Script
• Regis Gervier Global Head, mRNA Center of Excellence at Sanofi
• Philippe Kourilsky Professor Emeritus at Collège de France
• Marcel Hollenstein Group leader at Pasteur Institute
• Additional Speakers to be confirmed

12:05pm - 01:00pm

01:00pm - 01:55pm

Closing the gap in Women's Health : we need to be the change

• Elsy Boglioli Hofman Founder and CEO at Bio-Up (moderator)
• Bianca Coulter CEO at Coulter Partners
• Gonzague Issenmann Executive Chairman and CEO at Womed
• Marieta Jiménez Senior Vice President Europe at Merck Healthcare
• Jenny Yip Managing Partner at Adjuvant Capital
• Marcel van Duin VP, Head of External Innovation & Emerging Science at Organon

02:00pm - 02:55pm

Digital innovation tools empowering patients in collaboration with healthtech, pharma and investors

• Erik Tambuyzer President at ABConsult (moderator)
• Alain Herrera CMO at Phost’in Therapeutics
• Uroš Bogdanović Attorney at law at ANDRIĆ Attorneys-at-law, IDF Young Leader in Diabetes
• Anaïs Le Corvec Co-Founder at Cliclab Transformative Agent
• Marion Soto VP Business Development at Ariana Pharma
• Jenny Yip Managing Partner at Adjuvant Capital

02:55pm - 03:05pm

03:05pm - 03:45pm

Social impact of an effective North Atlantic Bridge for long-term innovation

• Pierre Courteille CCO & VP Business Development at Abivax (Moderator)
• Gabriela Apiou Director of Strategic Alliance of Massachusetts General Hospital Research Institute
• Additional Speakers to be confirmed

03:50pm - 04:30pm

Closing Ceremony with Institutional

• Institutional to be confirmed

04:30pm - 06:00pm